SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Servier at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Servier brings 4 presentations to SNO 2026 in Philadelphia. Its program centres on vorasidenib for IDH-mutant glioma, with updated INDIGO trial results and real-world adherence data. Its industry-supported sessions cover IDH-mutant glioma care.

OrganizationSNO 2026 Attendance
Servier
Suresnes, France
◆Platinum Supporter
Large pharmaPlatinum Supporter
An international pharmaceutical company developing and marketing medicines, including cancer therapies.
Talk
Fri Nov 13
7–8:15am
Clinical Crossroads of IDH-Mutant Glioma Care: Navigating Real-World Challenges and Complexities
Liberty Ballroom, Level 3, Philadelphia Marriott Downtown
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
One-year compliance to vorasidenib among patients with IDH-mutant glioma: real-world evidence from the GLIO-ADHERE study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract INNV-27
Survivorship
Talk
Sat Nov 14
7–8:15am

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Servier

Tell us what you sell and we’ll find the people at Servier most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction